People used these ANCC-CVNC Exam Braindumps to get 100% marks

All of us have been happy about our battle to help individuals pass the particular ANCC-CVNC exam. We possess our team linked to all the particular relevant folks supplying real ANCC (RN-BC) Cardiac-Vascular Nursing practice test. We develop our own ANCC-CVNC study guide database which is usually updated, validated plus tested on a normal basis. You may just register in order to download ANCC-CVNC Study Guide files along with VCE examination sim in order in order to practice and complete your exam.

Exam Code: ANCC-CVNC Practice test 2022 by team
ANCC-CVNC ANCC (RN-BC) Cardiac-Vascular Nursing

The ANCC Cardiac-Vascular Nursing board certification examination is a competency based examination that provides a valid and reliable assessment of the entry-level clinical knowledge and skills of registered nurses in the cardiac-vascular specialty after initial RN licensure. Once you complete eligibility requirements to take the certification examination and successfully pass the exam, you are awarded the credential: Registered Nurse-Board Certified (RN-BC). This credential is valid for 5 years. You can continue to use this credential by maintaining your license to practice and meeting the renewal requirements in place at the time of your certification renewal. The Accreditation Board for Specialty Nursing Certification accredits this ANCC certification

There are 150 questions on this examination. Of these, 125 are scored questions and 25 are pretest questions that are not scored. Pretest questions are used to determine how well these questions will perform before they are used on the scored portion of the examination. The pretest questions cannot be distinguished from those that will be scored, so it is important for a candidate to answer all questions. A candidate's score, however, is based solely on the 125 scored questions. Performance on pretest questions does not affect a candidate's score.

I Assessment and Diagnosis 31 25%
II Planning and Implementation 44 35%
III Evaluation and Modification 28 22%
IV Patient and Community Education 22 18%
TOTAL 125 100%

Assessment and Diagnosis
A. Knowledge
1. Anatomy and physiology
2. Pathophysiology
B. Skill
1. Patient interview (e.g., history, chief complaint, allergies)
2. Cardiac-vascular assessment techniques and tools (e.g., Doppler, stroke scale)
3. Data collection and interpretation (e.g., diagnostic tests, laboratory results)
4. Nursing diagnosis identification and prioritization
II Planning and Implementation
A. Knowledge
1. Evidence-based practice guidelines (e.g., ACC/AHA guidelines, quality measures)
2. Scope and standards of practice (i.e., cardiovascular nursing, vascular nursing)
3. Legal and ethical considerations (e.g., informed consent, advance directives)
4. Procedures (e.g., angiogram)
5. Surgeries (e.g., coronary artery bypass, carotid endarterectomy)
6. Pharmacologic therapies
7. Non-pharmacologic and complementary therapies
8. Risk-reduction measures (e.g., venous thromboembolism prophylaxis)
B. Skill
1. Care coordination (e.g., interdisciplinary teams, discharge planning)
2. Interventions (e.g., therapeutic hypothermia)
III Evaluation and Modification
A. Knowledge
1. Expected outcomes
2. Drug interactions (e.g., drug-drug, drug-food)
B. Skill
1. Adverse reactions and events (e.g., heparin-induced thrombocytopenia, hypotension) recognition and treatment
2. Urgent condition (e.g., pseudoaneurysm) recognition and treatment
3. Emergent condition (e.g., STEMI) recognition and treatment
IV Patient and Community Education
A. Knowledge
1. Cardiac-vascular risk factors (e.g., ethnicity, smoking)
2. Chronic disease management
3. Cardiac-vascular education subjects (e.g., procedures, medications)
4. Self-management strategies (e.g., daily weights, blood pressure logs)
5. Community resources (e.g., cardiac rehabilitation, anticoagulation clinic)
B. Skill
1. Individualized education planning and implementation (e.g., addressing barriers)
2. Home monitoring (e.g., remote telemetry, point-of-care testing)
3. Health promotion (e.g., wellness counseling, health fairs)

ANCC (RN-BC) Cardiac-Vascular Nursing
Medical Cardiac-Vascular teaching
Killexams : Medical Cardiac-Vascular teaching - BingNews Search results Killexams : Medical Cardiac-Vascular teaching - BingNews Killexams : Abbott is looking to address biases for cardiovascular patients
Portrait photo of Jennifer Jones-McMeans divisional VP of global clinical affairs at Abbott
Jennifer Jones-McMeans, divisional VP of global clinical affairs at Abbott [Image courtesy of Jones McMeans]
Earlier this year, Abbott’s (NYSE:ABT) vascular business released a supplement on gender and racial biases in cardiovascular care.

According to the 2021 ACC/AHA/SCAI guidelines for Coronary Artery Revascularization, women are less likely to receive cardiac catheterization and more likely to have worse outcomes than their male counterparts.

They’re also less likely to be recommended for cardiac catheterization compared to males, despite both parties having the same clinical guidelines, according to Abbott.

Abbott Divisional VP of Global Clinical Affairs Jennifer Jones-McMeans has been looking to address gender biases in cardiovascular care, particularly for women suffering from coronary artery disease (CAD) who report poorer clinical outcomes and patient experience compared to their male counterparts.

Jones-McMeans completed a Q&A with MassDevice on the topic. Here are her thoughts:

Q: If the clinical guidelines for both males and females are the same, what (if any trend or indicator has been observed) is behind the reduced likelihood of women receiving cardiac catheterization? 

A: Numerous factors contribute to this reduced likelihood, but almost all can be traced back to one simple fact: that, even though all sexes have the same basic heart anatomy, women with heart disease or cardiac events may present differently due to individual differences in physiology. In general, women have smaller coronary arteries and radial artery vessels, and they tend to have more comorbidities, such as diabetes or hypertension. Furthermore, natural hormonal phases and fluctuations have significantly impacted women’s cardiovascular health. For instance, post-menopausal women are at greater risk of cardiac events. Post-partum women with adverse pregnancy outcomes are also at high risk for future cardiac issues.

A difference of a few millimeters in artery size or a dip in estrogen levels may not seem significant, but those small differences compound when you consider the changes in how symptoms present, how medications are distributed through the body, and how medical devices are sized and inserted. For example, women have worse outcomes than men in percutaneous coronary intervention (or receiving a stent to treat coronary artery disease), most likely due to inaccurate estimation of the size of a stent needed for a woman’s smaller artery. In this way, physiological differences can contribute to the misdiagnosis and treatment of a cardiac event or illness, which results in women not receiving proper cardiac care as often as men, especially for women more than 65 years of age. 

Q: The increased likelihood of worse outcomes for females compared to males — can that be correlated to fewer catheterizations, or are there other factors at play? 

A: Multiple factors contribute to these outcomes, as discussed above. Misdiagnosis and ineffective treatment plans, including the lack of catheterization when warranted, will impact the patient’s outcomes and overall mortality rates. Treatment strategies should be based on the patient’s unique clinical presentation and take into account physiological differences. For example, there is evidence that a high-risk woman with a non-ST-elevation myocardial infarction might need more invasive strategies than a woman at low risk. During cardiac events, women are also less likely than men to report the “chest pain” commonly associated with heart attacks. Failing to account for such differences and individual risk levels in treatment plans can result in poor patient outcomes.  

With the impact of socioeconomic status, education, and healthcare access on medical care, do those tie into the inequities purely between males and females? For instance, are we seeing similar trends, and are the women less likely to receive cardiac catheterization tending to fall into that underserved community territory? 

A: Recent research has put data to a trend we have been seeing in the field for some time: women who present with heart disease are less likely to receive the care they needed and have poorer outcomes overall. Percutaneous coronary intervention (PCI) is a good example. This procedure involves using a catheter to install a device called a stent to open blood vessels. When treating women with PCI, there are several additional considerations.

In the words of Dr. Natalia Pinilla, “Women usually have smaller caliber blood vessels and more tortuosity. We are very cautious when doing heart interventions because there is a higher risk of complications; like blood vessel tears, due to vessel caliber and narrowing percentage overestimation. This is how procedural complications are higher in women population compared to men.” 

Social determinants of health (SDoH) also play a role here and impact the treatment of patients as well as access to diagnostic tools and quality care. Today, it’s well established that patients from historically oppressed or disadvantaged backgrounds have less access to quality care, on average. We see evidence of that in the fact that women and Black patients are much less likely than white men to receive invasive revascularization when presenting with a blocked artery.  

Q: What are the actions that can be taken to increase access (or buck trends if this is more of a care decision-making issue) so that women can begin to receive the proper care in this area? 

A: In addition to the adjustments to diagnostic measures and treatment plans mentioned above, we also need to think about how medical interventions are developed and tested today. This means diversifying clinical trials and ensuring they include women and people of color as participants. If a new cardiac stent is being evaluated, for instance, then the stent should be tested on men and women to ensure it is measured appropriately. After all, that’s not a one-size-fits-all situation. As clinical trials become more diverse, we hope to see more nuance in the applications for medical interventions and devices for women and people of color presenting with cardiac disease. 

Q: If you can provide a status update on the Beyond Intervention initiative (what the aim of the new supplement is, if any new data worth mentioning has come in, etc.), that would be great as well. 

A: We launched the Beyond Intervention initiative in 2020 to analyze the vascular care landscape, adjust care to better meet the unique needs of diverse patient populations, and re-envision the future of vascular care. Although heart disease is the leading cause of death for women in the U.S., women account for just 38% of participants in cardiovascular clinical trials (despite being about 50.5% of the U.S. population). Our goal is to create a reality in which the percentage of those treated within clinical trials matches the percentage of those burdened with the disease. 

This supplement, “Addressing Racial and Gender Bias in Cardiovascular Care: Why Improving Health Equity Is an Urgent Need for the Healthcare Community,” shines a light on many of the issues we’ve discussed, providing scientific data and experiential insight into the cardiac care experience for women. For example, women have reported experiencing more challenges than men in their cardiac care, including access to care and good relationships with their physicians. Marginalizing women’s vascular health has clinical and economic consequences directly at odds with the ideals of the Institute for Healthcare Improvement’s “Triple Aim” initiative, which seeks to Excellerate population health, Excellerate patient experience and quality of care, and lower the cost of care. 

This supplement also proposes a solution to the challenges we’ve discussed: health equity. In particular, conscious inclusion in every element of the healthcare industry, from R&D to clinical research to trial participant demographics and primary care providers. Clinical trials need to be representative of women and other under-represented groups. If we are to better understand and treat the diverse patient population of the U.S., we need diverse and inclusive researchers and caregivers. 

Mon, 08 Aug 2022 05:16:00 -0500 Sean Whooley en-US text/html
Killexams : New Intensive Cardiac Rehab Program at Modern Heart and Vascular Institute

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

HUMBLE, Texas, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Modern Heart and Vascular is now offering intensive cardiac rehabilitation for patients who have recently suffered from a heart attack, undergone bypass surgery, have chest pain, and others. 

The expert team at Modern Heart and Vascular is focused on ensuring patients’ hearts beat stronger and healthily. The experienced team including exercise specialists, dietitians, nurses and other medical personnel are ready to help patients regain their strength and stamina. 

Benefits of Intensive Cardiac Rehab Include:

  • Reducing the number of medications taken
  • Avoiding future procedures and surgeries
  • Lowering blood pressure, cholesterol and sugar
  • Improvements in daily symptoms
  • Longer life with improved quality of life
  • Improved self-confidence and well being
  • And much more...

The intensive cardiac rehabilitation program includes orientation, one-on-one progress meetings, exercise sessions, education and specially trained staff.

The intensive cardiac rehab center is located at 18648 McKay Drive Suite 110 Humble, TX 77338.

For comprehensive cardiovascular care, contact Modern Heart and Vascular Institute by phone or online today. Same-day appointments are available to suit your needs. The majority of insurance plans (including commercial, Medicare, and Medicare replacement) are accepted.


Modern Cardiovascular Care for Modern Patients Using Modern Technology

Modern Heart and Vascular Institute
Phone: 832-644-8930

Related Images

Image 1: Modern Heart and Vascular

Modern Heart and Vascular Logo

This content was issued through the press release distribution service at


Mon, 08 Aug 2022 02:02:00 -0500 en text/html
Killexams : Yale University: Uncovering New Approaches to a Common Inherited Heart Disorder

Research led by Muhammad Riaz, PhD, Jinkyu Park, PhD, and Lorenzo Sewanan, MD, PhD, from the Qyang and Campbell laboratories at Yale, provides a mechanism to identify abnormalities linked with a hereditary cardiac condition, hypertrophic cardiomyopathy (HCM), in which walls of the left ventricle become abnormally thick and often stiff. The findings appear in the journal Circulation.

Patients with familial HCM have an increased risk of sudden death, heart failure, and arrhythmias. HCM is the most common inherited cardiac disease, affecting one in 500 people. The disease is thought to be caused by mutations that regulate cardiac muscle contraction, compromising the heart’s ability to pump blood. However, the mechanisms behind the disease are poorly understood.

For this multi-model study, the researchers used stem cell approaches to understand the mechanisms that drive inherited HCM. The technology, induced pluripotent stem cells (iPSCs), can accelerate insights into the genetic causes of disease and the development of new treatments using the patient’s own cells.

“This is a humbling experience that a patient’s disease phenotypes teach researchers fundamental basic knowledge that sets the stage for innovative new therapies. Furthermore, our research has established a great model to assist many physicians at Yale School of Medicine and Yale New Haven Hospital to unravel mechanistic insights into disease progression using the patients’ own iPSCs and engineered tissues,” said Yibing Qyang, PhD, associate professor of medicine (cardiology) and of pathology.

“We wanted to understand the disease mechanism and find a new therapeutic strategy,” Park said.

Probing the heart disorder’s mechanism
The concept originated with an 18-month-old patient who suffered from familial HCM. Through a collaboration with Daniel Jacoby, MD, adjunct associate professor of cardiovascular medicine and an expert on HCM, who provided medical care for this patient, Park and the team used stem cell technologies to address a fundamental question, the disease mechanisms behind HCM. They collected 10 cc of the patient’s blood and introduced stem cell factors into the blood cells to generate self-renewable iPSCs. By applying cardiac knowledge, they coaxed iPSCs into patient’s own cardiomyocytes (heart cells) for cardiac disease studies. “We discovered a general mechanism which explains the disease progression,” said Park.

Next, they engineered heart tissues that resembled the early-onset disease scenario of the young patient. The disease was a severe presentation at the age of 18 months, which suggested that the disease started at the fetal/neonatal stage.

The next phase of the study was to recreate a 3-D model that was used to mimic the progression of the disease, including mechanical properties such as contraction and force production of that muscle, to understand how much force is compromised if the mutation is present. This was performed in collaboration with Stuart Campbell, PhD, and Sewanan from Yale’s Department of Biomedical Engineering. Coupled with computational modeling for muscle contraction, the authors developed robust systems that allowed them to examine the biomechanical properties of the tissue at three-dimensional levels.

Finally, using advanced gene editing technologies, the research team modified these mutations. They discovered that after the mutations were corrected, the disease was reversed. These insights about sarcomeric protein mutations could lead to novel therapeutics for HCM and other diseases. The interaction between mutations could also suggest that the same biomechanical mechanism exists in other conditions such as ischemic heart disease.

Our research has established a great model to assist many physicians at Yale School of Medicine and Yale New Haven Hospital to unravel mechanistic insights into disease progression using the patients’ own iPSCs and engineered tissues.

Yibing Qyang, PhD
“We can apply these findings to cardiac conditions associated with hypertension, diabetes, or aging,” said Riaz.

Applying the findings to heart disease
“One of the fundamental challenges was that we needed to generate iPSCs from the patient’s family,” Riaz added. Using this technology, Park was able to recreate primary cells from the cells of a patient with HCM, a process which takes over a month. Riaz and Park used stem cells to identify the vital role of pathological tissue remodeling, which is caused by sarcomeric hypertrophic cardiomyopathy mutations.

“We are hopeful that our findings will be replicated in the scientific community,” said Riaz. “This is an example of bed to bench research, where scientists extract materials from clinics and conduct the experiment in the laboratory and then discover new methods to treat patients.”

The authors also noted that RNA sequencing could be used as a guide to characterize the disease at a molecular level. Scientists may be able to identify more targeted drugs by examining the biomechanical properties of the tissue. “We can now screen multiple drugs to see whether any of those drugs are able to rescue the phenotype,” they said.

Riaz, now an associate research scientist in the Qyang lab, began as a cancer researcher. He earned a PhD from the Erasmus University Medical Center, based in Rotterdam, Netherlands. He later studied genetic disorders in skeletal muscle disease before joining the lab in 2017.

Park, also from the Qyang lab, graduated from Seoul National University, South Korea in 2013. He completed postdoctoral research at the University of Missouri where he focused on vascular biology and emerging areas in stem cell technology.

Mon, 08 Aug 2022 23:55:00 -0500 en-US text/html
Killexams : Vascular diseases on the rise, but surgeons too few, says Health Minister

For a population of about 1.3 billion, India has only around 500 vascular specialists, said Health and Medical Education Minister K. Sudhakar on Saturday, stressing the need to create increased awareness on vascular diseases in the country.

"Vascular disease is a lifelong medical condition that can lead to complications such as amputation (loss of a limb), poor wound healing, restricted mobility due to pain or discomfort,” the Minister said.

Speaking after flagging off a walkathon organised by Vascular Surgeons Association of Karnataka (VASKAR) on the occasion of National Vascular Day, the Minister said although vascular diseases are on the rise, we have limited vascular surgeons in the country.


The walkathon with a theme “Save Limb, Save Life” was taken out from Town Hall to Kanteerva Stadium. Kannada cine actors — Prajwal Devaraj and Prem — were among the celebrities who took part in the walkathon.

“We have to ensure a strict health regimen to protect our blood vessels. If this is not done, it could lead to severe health problems including non-communicable diseases. These in turn could cause life threatening situations,” the Minister said.

Pointing out that some people are prone to vascular diseases, he said, “Every six seconds, a person loses his/her leg in the world. We need to increase awareness among youngsters and those who are prone to such issues because of their professions such as policemen and teachers who stand for long periods of time. Awareness must also be created among professionals who have to work in front of computers for long periods of time, who have a sedentary lifestyle.”

Indians susceptible

Vivekanand, president of VASKAR, said the disease strikes Indians at a younger age, with over half of cardiovascular disease deaths happening in people under the age of 50. Smoking, dyslipidemia, and hypertension in the young are some of the other risk factors.

Quoting data from the American Heart Association, the doctor said around 150,000 non-traumatic amputations are performed each year.

“Vascular illness develops when the arteries that carry blood from the heart to the rest of the body constrict, limiting blood and oxygen flow. It mainly affects the legs and feet, causing symptoms such as cramping, weakness, weariness, soreness, pain, or discomfort while walking that goes away after 10 minutes of rest,” he said, adding that it should not be ignored.

Sat, 06 Aug 2022 01:14:00 -0500 en text/html
Killexams : How Social Isolation, Loneliness Can Affect Heart Health, Cognitive Abilities
  • A new study reports that social isolation can increase a person’s risk of heart attack and stroke.
  • Another new study concludes that loneliness can lead to cognitive decline.
  • Experts say older adults can lower their risks by being socially active, eating a healthy diet, and exercising regularly.
  • They also encourage family members to stay involved with older relatives to prevent them from becoming socially isolated.

Older adults who are lonely, socially isolated, or do not participate in engaging activities are at risk for heart attack, stroke, and Alzheimer’s disease, according to a pair of studies released this week.

The first study, published in the Journal of the American Heart Association, found that social isolation and loneliness might increase the risk of either heart attack, stroke, or death. The data showed that being socially disconnected can increase the risk of heart attack by 29 percent and stroke by 32 percent.

The researchers defined social isolation as having infrequent in-person contact and social relationships with different groups, such as friends, colleagues, family, and members of community groups, such as religious organizations.

People with three or fewer social contacts per month could have a 40 percent increased risk of recurrent heart attack or stroke, the researchers reported.

They noted that the risk of social isolation increases with age due to widowhood, retirement, and friends and family passing away. Social isolation affects nearly one-fourth of adults over 65 and estimates indicate that between 33 and 47 percent of older adults are lonely.

However, social isolation and loneliness are not limited to older adults. Generation Z, young adults between 18 and 22, is characterized as the loneliest generation. This might be because they engage in less meaningful in-person activities and use social media more than other generations.

The COVID-29 pandemic also increased social isolation in several groups, including people between 18 and 25, older adults, women, and low-income individuals.

The new study found that:

  • Social isolation and loneliness are common but are under-recognized as contributing to cardiovascular and brain health.
  • The lack of social connection is associated with an increased risk of premature death from all causes, especially among men.
  • People who experience social isolation or loneliness are more likely to experience chronic stress and depression. Depression can also lead to social isolation.
  • Social isolation in childhood is associated with obesity, high blood pressure, and increased blood glucose levels.

The researchers reported that people with a higher risk of social isolation and loneliness include:

  • Those in underrepresented racial and ethnic groups
  • People who identify as lesbian, gay, bisexual, transgender, and queer (LGBTQ)
  • People with physical disabilities, including vision and hearing impairments
  • People living in rural areas and areas with limited resources
  • People with limited access to technology and the internet
  • Recent immigrants
  • Those incarcerated

The second study, published in the online issue of Neurology, the American Academy of Neurology’s medical journal, looked at why some people with amyloid plaques in their brains associated with Alzheimer’s disease show no sign of the disease.

In contrast, others with similar plaques have memory and cognitive issues.

The researchers hypothesized that genetic and life factors can create a cognitive reserve that helps protect the brain. Participating in clubs, religious groups, sports, artistic activities, and education before age 26 may affect the brain’s cognitive reserve. Continuing to learn throughout life could also protect the brain from dementia.

“Although cognitive decline can’t be cured, it may be prevented by implementing activities, which are beneficial to build new neural pathways and connections in the brain, helping to keep the mind sharp and putting it to work,” Dr. Sameea HusainWilson, director of movement disorder neurology at Baptist Health’s Marcus Neuroscience Institute in Florida, told Healthline. “Good choices include puzzles Sudoku, games, music, card games, reading, playing instruments, or practicing hobbies in which the mind must think outside everyday tasks.”

The latest study involved 1,184 participants who were born in 1946 in the United Kingdom. Each participant took two cognitive tests – one at 8 years of age and again at 69 years old.

The researchers found that higher childhood cognitive skills, a higher cognitive reserve index, and higher studying ability were all associated with higher scores on the cognitive test taken at 69 years.

Other findings included:

  • College education played a part in higher scores. Individuals with a bachelor’s degree or higher scored 1.22 points more on average than those without a formal education.
  • Leisure activities also raised cognitive scores. Those who engaged in six or more leisure activities, such as adult education classes, clubs, volunteer work, social activities, or gardening, scored 1.53 points more on average than people who engaged in only four activities.
  • Those with a professional or intermediate level job scored 1.5 points more on average than those with partly skilled or unskilled occupations.

In an editorial that accompanied the study, Michal Schnaider-Beeri, PhD, a professor of psychiatry in the Icahn School of Medicine at Mount Sinai in New York, said: “From a public health and societal perspective, there may be broad, long-term benefits in investing in higher education, widening opportunities for leisure activities and providing challenging cognitive activities for people, especially those working in less skilled occupations.”

Husain-Wilson suggests the following to keep your mind challenged and slow the progression of cognitive decline:

  • Decrease red meat in your diet and increase seeds, vegetables, and fruits
  • Get regular exercise
  • Engage in mental exercises such as reading, crossword puzzles, art, card games, and arts and crafts
  • Feed your mind-body connection with activities such as yoga, meditation, and social engagement
  • Learn something new, such as learning an instrument or taking on a new hobby

It helps when older adults are proactive in finding ways to socially engage with others.

“Start small; a phone call, text, or note to reconnect with acquaintances and family,” suggests Dr. Sandra Narayanan, a vascular neurologist and neuro-interventional surgeon at Pacific Stroke & Neurovascular Center at Pacific Neuroscience Institute in California.

“Come away from social interactions with a plan to increase engagement (if mutually desirable.) Make plans to follow up,” Narayanan told Healthline. “Don’t assume that someone will reach out to include you, especially if you turned down social interactions in the past.”

“Being actively involved in community resources, such as senior centers helps older adults maintain independence. Engaging in church or faith activities and groups can provide spiritual and emotional support,” added Dr. Estefania Maurer Spakowsky, a physician with AltaMed Health Services Program of All-Inclusive Care for the Elderly (PACE).

“A large proportion of older adults have physical and cognitive limitations,” Spakowsky told Healthline. “We can contribute to improving wellness by being mindful of these limitations during family time and social gatherings, as well as include activities that seniors can participate.”

Experts say emotional health and physical health are interrelated and tend to be cyclical. Social isolation can cause depression and depression can contribute to social isolation.

“Depression is significantly higher in the elderly population due to social isolation and contributes negatively on their health. Older adults who are depressed tend to have issues with memory, regularly eating, physical activity, and decreased adherence to medications,” explained Spakowsky. “Empowering and motivating older adults, providing resources to engage in activities and socialize with peers will positively impact their health.”

There are specific things family members can do to help engage their elderly relatives. Narayanan provides some suggestions:

  • Be welcoming and respectful of the older adult’s lived and current experience
  • Be cognizant of barriers limiting desire to participate, such as widowed or single status, feeling like the odd person out, self-consciousness about joining younger groups
  • Work with relatives if there is limited mobility, inability to drive or access transportation, or the need to coordinate outings with medication schedules or medical appointments
  • If possible, bring the activity to the older adult to overcome barriers and minimize absenteeism

“As time passes and mutual engagement increases, the desire to venture out with diverse groups might increase,” added Narayanan

Wed, 03 Aug 2022 15:40:00 -0500 en text/html
Killexams : Kamineni Education Society Celebrates 20th Foundation Day

Narketpally: Kamineni Education Society (KES) is the Education Division of Kamineni Hospitals Group celebrated its 20th Foundation Day at its KIMS campus at Narketpally today. KES has been providing distinguished service in the field of medicine and education.

Dr. Shashidhar Kamineni, Secretary, KES, inaugurated the programme by lighting a traditional lamp in the presence of Dr. Vivek Jawali, renowned Chief Cardiothoracic & Vascular Surgeon Dr. Thimmannagowda Patil, Senior Cardiac Anaesthesiologist, Dr. Gayatri Kamineni, Dr Sai Surya Kiran Kamineni, Senior officials of the society, principals, deans and students of educational institutions who attended the grand event.

As part of the celebrations, KES applauded the achievements of the students. 60 students who secured the highest marks in various subjects in the college were felicitated with certificates, gold medals and cash prize.

Speaking on the occasion Chief Guest Dr. Vivek Jawali, renowned Chief Cardiothoracic & Vascular Surgeon, said, “A hearty congratulations to the students who have proved that they have the capacity to reach the zenith of success. I have been watching Kamineni since 1999, college has grown extensively and infrastructure many time for the benefit of students. The present medical students have tremendous opportunities in various fields to excel and grow in their respective careers. The cycle of pursuing medicine is difficult, learn better and think better for your future Joy and Elaxations.’’

Speaking on the occasion Dr. Thimmannagowda Patil, Senior Cardiac Anaesthesiologist said, “Addressing the future medical doctors that they have to work hard in their medical profession and success & monetary benefits will follow automatically.”

Commenting on the occasion Dr. Shashidhar Kamineni, Managing Director, Kamineni Hospitals and Secretary, KES, said, “It is a great pleasure for Kamineni Educational Society to celebrate its 20th foundation day. Since its inception, this society has provided quality education to many students. Students who have passed out of here have settled in very high positions in the country and abroad. I wish those who are currently studying here to be well established in their professional and personal lives. Those who are desparate to serve others, would do well in the medical profession. I thank all of you who have been with us and supported our development for more then 20 years.”

With a vision to Excellerate education in the healthcare space Kamineni Group has set up the Kamineni Institute of Medical Sciences (KIMS), Kamineni Academy of Medical Sciences and Research Centre (KAMSRC), Kamineni Institute of Dental Sciences (KIDS), Nursing Schools & Colleges and Institutes of Paramedical Courses under Kamineni Education Society (KES). The Kamineni Group operates 3 super speciality hospitals on the name of Kamineni Hospitals (LB Nagar, Kingkoti, Vijayawada) to offer responsible and quality healthcare of the highest standards while making it affordable at the same time.

KES provides quality education to its students. It also conducts free health camps in the villages of Nalgonda district. KES is involved in charity work for the poor and deserving, irrespective of caste, creed, race or religion.

Mon, 08 Aug 2022 23:23:00 -0500 en-US text/html
Killexams : Red Meat Increases Risk of Cardiovascular Disease by 22 Percent per Serving

Eating just one serving of red meat can substantially increase risk of cardiovascular disease, a new study found. A serving of red meat that is eaten and digested in the intestinal tract results in gut microbes producing chemicals that increase the risk for cardiovascular disease by 22 percent, according to a study published in the medical journal Arteriosclerosis, Thrombosis, and Vascular Biology

The study, led by researchers at the Friedman School of Nutrition Science and Policy at Tufts University and Cleveland Clinic Lerner Research Institute, aimed to quantify the risk of cardiovascular disease associated with meat intake and identify the underlying biologic reasons that may help explain the risk. 

The study involved almost 4,000 American men and women over age 65, with an average age of 73, and showed that higher meat consumption is linked to higher risk of cardiovascular disease—22 percent higher risk for approximately every 1.1 serving per day. About 10 percent of this elevated risk is explained by increased levels of three metabolites produced by gut bacteria from nutrients abundant in meat. In the study, higher risk and the link to gut bacterial metabolites were found for red meat specifically. 

The study is the first to investigate the relationship between animal foods, the risk of cardiovascular disease, and the mediation of this risk by gut microbiota-generated compounds as well as by traditional heart disease risk pathways such as blood cholesterol, blood pressure, and blood sugar. 


Red meat increases risk of cardiovascular disease

The research drew on years of data from the National Institutes of Health’s Cardiovascular Health Study, a long-term observational study of risk factors for cardiovascular disease in Americans aged 65 and older. The study adjusted for established risk factors such as age, sex, race/ethnicity, education, smoking, physical activity, other dietary habits, and many additional risk factors. Several blood biomarkers were measured at baseline and again during follow-up, including levels of the gut-microbiome generated trimethylamine N-oxide (TMAO) and two of its key intermediates, gamma-butyrobetaine and crotonobetaine, derived from L-carnitine, which is abundant in red meat. 

“Interestingly, we identified three major pathways that help explain the links between red and processed meat and cardiovascular disease—microbiome-related metabolites like TMAO, blood glucose levels, and general inflammation—and each of these appeared more important than pathways related to blood cholesterol or blood pressure,” study co-senior author Dariush Mozaffarian, Dean for Policy at the Friedman School, said in a statement. “This suggests that, when choosing animal-source foods, it’s less important to focus on differences in total fat, saturated fat, or cholesterol, and more important to better understand the health effects of other components in these foods, like L-carnitine and heme iron.”

In this cohort of older US men and women, higher intakes of unprocessed red meat, total meat (unprocessed red meat and processed meat), and total animal source foods were prospectively associated with a higher incidence of cardiovascular disease during a median follow-up of 12.5 years. 

The study authors noted that more research is needed to determine if the findings are generalizable across ages and nationalities. And while microbiome biomarkers were directly measured in the blood, the dietary habits of study participants were self-reported, and study findings are observational and cannot prove cause-and-effect.

“These findings help answer long-standing questions on mechanisms linking meats to risk of cardiovascular diseases,” study author Meng Wang, a postdoctoral fellow at the Friedman School, said in a statement. “The interactions between red meat, our gut microbiome, and the bioactive metabolites they generate seem to be an important pathway for risk, which creates a new target for possible interventions to reduce heart disease.”  


How to help prevent heart disease

The new study provides a potential new target for preventing or treating heart disease in a subgroup of people who consume excessive amounts of red meat. Based on previous studies that have pointed to the negative effects of animal products on heart health, medical experts and organizations encourage patients to follow current recommendations for a heart-healthy lifestyle, including adapting a healthy diet that is rich in vegetables, fruits, whole grains, and other heart-healthy foods—and eating less or no meat.

Currently, the American Heart Association says a healthy diet and lifestyle are key to managing and preventing cardiovascular disease. This includes maintaining a healthy weight, regular exercise, and a diet that emphasizes a variety of fruit and vegetables, whole grains, and healthy sources of protein mostly from plants such as legumes and nuts.

Additionally, according to research published in the Journal of the American Heart Association, diets that focus on nutritionally rich plant foods can give young adults a healthier heart, lowering their risk of cardiovascular disease by 52 percent. The 32-year study found that even participants who shifted to a plant-based diet as they aged gained heart-protective benefits, regardless of the quality of their original diet. 

Another study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism specifically pointed to dinner as the pivotal meal that determined one’s risk. Data collected from over 27,000 adults extracted from the National Health and Nutrition Examination Survey found that those who consumed a plant-based diet rich in whole carbohydrates and low in saturated fats reduced their risk of heart disease by up to 10 percent. 

For the latest vegan news, read:
Lizzo Blazes Through ‘Hot Ones’ With Help From Daring Vegan Chicken
Vegans Who Lift Weights Have Better Bone Strength, Study Finds
Will This Cultured Palm Oil Be the Solution to Saving the Orangutans?

Vote in the 2022 Best Vegan Ice Cream in America Awards.


Mon, 08 Aug 2022 02:02:00 -0500 en-US text/html
Killexams : Buffalo center fuels research that can save your life from heart disease and stroke

Dr. Jennifer Lang splits most of her work life treating patients at Gates Vascular Institute and conducting research in her lab several floors up in the same building.

UB medical physics students Simon Wu and Emily Vanderbelt work with flow-through 3D-printed aneurysm models using X-rays in the Canon Stroke & Vascular Research Center, part of the University at Buffalo Clinical and Translational Research Center on the Buffalo Niagara Medical Campus.

The arrangement suits her well as she continues promising research to learn if a stem cell-derived treatment can repair damaged heart tissue.

Lang, a cardiologist, and her University at Buffalo team, face a dilemma: The immune system revs into high gear when the heart suffers a serious setback, limiting the power of stem cells to heal.

The daunting task seems more surmountable these days because she works in a building filled with researchers of all stripes.

“I do collaborations with groups that I otherwise wouldn't have. It’s led to some really new, interesting results,” said Lang, assistant professor in the UB Jacobs School of Medicine and Biomedical Sciences who practices with UBMD Internal Medicine and at the Buffalo VA Medical Center.

People are also reading…

This day, a surgical team worked seamlessly to monitor her vital signs and feather a medical device through a catheter into the left side of her damaged heart. The procedure slowed her heartrate so her organs could take a couple of days to re-collect themselves and give her a fighting chance to recover.

UB-fueled research unfolds on floors five through eight of the building at 875 Ellicott St., alongside Buffalo General Medical Center.

Ten years ago, the university invested $118 million into its Clinical and Translational Research Center, and about $25 million for equipment came from industry partners who wanted to join forces with physicians, engineers and others in the science fields.

The center became the first major piece of the UB medical school to move onto the downtown Buffalo Niagara Medical Campus, followed in late 2017 by the $375 million Jacobs School teaching and research complex, around the corner at Main and High streets.

Both foster translational medicine, which combines disciplines, resources and techniques to move benchtop research to the patient bedside, eventually strengthening community health.

Lang’s work symbolizes the approach.

The Buffalo native can see her high school alma mater, City Honors, from her workplace. She went to Cornell University as an undergraduate and returned to Buffalo to go to medical school. Buoyed by fellow UB students, faculty and mentors, she chose to stay in the city for her internal medicine residency and cardiology fellowship.

Lang did her classroom work and research on the UB South Campus and most of her clinical work 8 miles away, on the downtown Medical Campus.

Stairs and elevators are the only things that separate her from most of her collaborators and patients today.

“I moved into this building when it opened 10 years ago,” she said. “At the time, I was completing my cardiology fellowship. There was a physical divide, so I was thrilled with the new arrangement. Things can happen in parallel now.”

Dr. Timothy Murphy, left, director of the UB Clinical and Translational Research Center in Buffalo, works with research technician Charmaine Kirkham in their lab, which focuses on potential treatments for chronic obstructive pulmonary disease (COPD). 

That was the plan, said Dr. Timothy Murphy, director of the UB Clinical and Translational Research Center.

“Clinical research and health care have become more and more seamlessly integrated,” he said. “The building contributed to that.”

Murphy, another regional native, was among those who shared – and helped carry out – the vision of Gates Vascular Institute founder Dr. L. Nelson “Nick” Hopkins III, who chaired the UB Department of Neurosurgery from 1989 to 2013 and wanted to create a more innovative vascular center.

Murphy moved his lab in 2006 from the VA Medical Center near South Campus to the UB Center for Bioinformatics and Life Sciences on the Medical Campus, so he could be involved in the design of the UB research center, on floors above Gates Vascular, as well as at the Jacobs School – particularly its labs.

“They always talked about physicians and researchers bumping into each other, talking to each other, and having graduate students and postdocs and technicians talk to each other,” Murphy said. “Having done it now for all these years, I see it really does work.”

He and his research team continue a 20-year study on the bacterial infection that causes COPD in hopes it will help lead to vaccines that prevent the infection and new treatments to clear the bacteria from the lower airway.

As senior associate dean for clinical and translational research at the Jacobs School, he is also the point person for coordinating UB-related clinical trials and encouraging “collisions” between health care researchers on the Medical Campus – and around the world.

There were 70 such trials on the Medical Campus in 2015, when the building where he works was in its infancy. Today, there are more than 200.

"Things can happen in parallel now," says Dr. Jennifer Lang, a cardiologist, researcher and University at Buffalo assistant professor who splits her research and clinical time in the same building on the Buffalo Niagara Medical Campus.

Labs focused on obstetric and gynecological advances and keys to healthy aging occupy space near his seventh-floor lab.

The Clinical and Translational Research Center was established in 2012. UB added a biobank in 2019 to store medical specimens for ongoing clinical studies.

Its collaborative framework helped UB land a $15 million Clinical and Translational Science Award in 2015 from the National Institutes of Health (NIH) to encourage research efforts across university departments and specialties to boost innovation, speed development of medical treatments, and reduce health disparities in poor, rural and minority communities.

The five-year grant was renewed in 2020 with nearly $22 million more, encouraging Buffalo-based researchers to work with others who got awards, including researchers with Harvard, Johns Hopkins, Stanford and Yale universities.

A printer creates a 3D model, slice by slice, at the Canon Stroke & Vascular Research Center in the University at Buffalo Clinical and Translational Research Center. Lab researchers experiment with different mixtures of six polymers to make the most malleable and useful models for medical research. 

Throughout the building, the goal is to Excellerate medical devices and treatments that make an impact in the clinics and catheter suites in the Gates Vascular Institute on the floors below the research center – and provide data and education that informs others, including patients.

The eighth-floor Canon Stroke & Vascular Research Center, which tops the UB research center, is a case in point.

Ciprian “Chip” Ionita, its director, came to UB from Romania in 1999 and worked his first dozen years on the South Campus.

“We were the first ones to move in,” said Ionita, assistant professor of biomedical engineering and member of the medical school's Department of Neurosurgery.

The lab was designed to help innovate and Excellerate medical devices and neurovascular procedures.

Part of its work involves using MRIs, CT scans and other radiological images of Gates Vascular patients to create 3D-printed models of the circulatory system and heart.

3D printing created this replica of part of a patient's spinal column at the Canon Stroke & Vascular Research Center. Researchers there push the boundaries until their findings are refined to the point where they can be applied to model-making on two highly calibrated 3D printers in the Jacobs Institute downstairs from the lab that meet FDA standards. “We fail up here about 90% of the time,” says Ciprian “Chip” Ionita, lab director. “They fail maybe 1%, so we’re testing everything that's possible.”

Medical school and other lab researchers use the models produced here to better understand how anatomy and disease of former and current patients led to poor health and, in some cases, poor surgical outcomes.

Gates Vascular surgeons also can use 3D models that replicate the anatomy of patients awaiting surgery to practice feathering catheters and medical devices through bends, nooks and crannies of the blood vessels, and deploy medical devices in spines and the circulatory system as they maneuver past muscles, bones, blockages and other obstructions that might come into play.

“During practice interventions, we analyze everything,” Ionita said, “because we can go into these models with sensors” to measure blood flow, blood pressure and more.

“You can create a model that says, ‘Here's somebody who has a carotid artery that's 50% (blocked) and he's 50 years old,’ ” Ionita said. “Or we can say, 'Here is a young person in their 20s, and is fully compliant, no stenosis or whatever.' And those mechanical properties are translated by the printer.

“Even cadaver donors can’t do that.”

The goal is to lower the rate of complications “and be successful in one shot during a procedure,” said Ionita, who supervises up to 10 graduate biomedical engineering students, and roughly 20 undergraduate, graduate and medical school students.

Those who pay close attention to 3D models and other medical research based on data from patients treated in the building include Dr. Elad Levy, co-director of the Gates Vascular Stroke Center; Dr. Adnan Siddiqui, director of neurological and stroke services at Kaleida Health; and Dr. Vijay Iyer, medical director of cardiology and the Structural Heart Program at Kaleida. All three have ties to UB.

Even here, Ionita said, physician-scientists and other researchers see the damage that smoking, high blood pressure and living in ZIP codes where poverty is rampant can create complications that lead to worse health and surgical outcomes.

Eric Wozniak, a senior research and development technician in the Idea to Reality lab at the Jacobs Institute, uses a microscope as he works to Excellerate catheter technology.

Doctors and staff Excellerate treatment protocols and surgical prowess with help from those who work on the top half of the building for UB and the Jacobs Institute. The latter is named for Dr. Lawrence D. Jacobs, a Buffalo neurosurgeon whose research led to the first treatments for multiple sclerosis.

Four years after Jacobs died in 2001, his brother Jeremy, chair of the Delaware North Cos. and the UB Council, approached the university about creating a lasting memorial for the respected physician. He later signed on to the concept of creating a multidisciplinary vascular center, starting with a $10 million donation for the institute that bears the family name.

The institute includes an atrium, café and glass-walled spaces that overlook procedure rooms on the floor below. It has 50 employees, including more than 30 biomedical and electrical engineers, who seek company-sponsored research funding, help collect data and make prototypes for clinical trials, and work with researchers to publish their work in medical journals.

In 2016, the institute was designated a 3D Printing Center of Excellence in Health Care by Israeli-based Stratasys Ltd., a leading 3D printing-maker. In early 2018, it created a proof-of-concept Idea to Reality Center, known as i2R, to further Excellerate medical devices and surgical techniques in the vascular space.

“This is our secret sauce lab,” said Siddiqui, Jacobs Institute CEO. “There's nothing we do downstairs that we could not do better.”

This is a device designed and built in the Idea 2 Reality lab at the Jacobs Institute in Buffalo. The lab improves medical devices and technology used in vascular procedures and treatments.

Dr. Carlos Pena, who ran the FDA Neurologic Devices Division for 15 years, joined the institute staff last year to Excellerate the chances technology conceived and designed with help from the institute gets to market.

“Every company wants to talk to him,” Siddiqui said. “He tells them what testing needs to be done. Some of that gets done in-house. A lot of it goes to the university or, when they have a clinical trial, that gets done downstairs – so the entire ecosystem is functioning, I think better than Nick Hopkins ever imagined.”

Lang, the cardiologist, doesn’t miss her former workday commutes. She loves the design and location of the building that sets the standard for vascular care.

Most of her days mix benchtop research in her lab and patient visits and procedures on the floors below. When there is time, she can visit her husband, Fraser Sim, neuroscience director and associate professor at the medical school.

“Because we're in such close proximity to the Jacobs School now, we're also really able to engage the medical students earlier in their careers and encourage more research,” Lang said. “And because we're so close to the hospital, we're able to involve medical residents and fellows in our research projects much more than ever before.”

University at Buffalo medical school postdoctoral research associate Touba Tarvirdizadeh focuses on cardiac research in the lab of Dr. Jennifer Lang at the UB Clinical and Translational Research Center in Buffalo.

She has spent a decade trying to find better ways for a stem cell derivative that can withstand an immune response and rejuvenate heart tissue without major complications, a result that could help patients recover from a heart attack and lessen the strain of heart failure.

Four years ago, Lang and her doctoral student researcher, Kyle Mentkowski, discovered a way that lowered the immune response in mice that received the derivative.

Mentkowski, now a post-doctorate researcher at Harvard-affiliated Massachusetts General Hospital, was talking with another group of student researchers in the building when they thought it might be a good idea to bring Dr. Jessica Reynolds, an immunologist and UB medical school associate professor, into the research.

The collaboration created robust, reproducible results in mice models, Lang said, and the start of testing in human immune cells she and her colleagues hope can benefit patients within the next decade.

Collaborators now regularly get together to chat at the Jacobs Institute.

“The NIH seems very interested in this as a potential clinical therapy,” Lang said, “but the field as a whole is still in the beginning stages of understanding where we need to go next.”

Dr. Aaron Hoffman, left, University at Buffalo medical school associate professor of surgery, and Dr. Kenneth Snyder, UB associate professor of neurosurgery, chat during a break in the Jacobs Institute atrium.

UB researchers have shared some of their findings with researchers making similar inroads elsewhere, she said, and the work spawned other collaborations with Reynolds, her research team and scientists in the UB Department of Biomedical Engineering.

“This type of unplanned interaction is not a unique occurrence in this building,” Lang said. “Our story is just one of many.”

Thu, 28 Jul 2022 22:00:00 -0500 en text/html
Killexams : Gut microbe response to digestion may help explain cardiovascular disease risk related with red meat intake

Chemicals produced in the digestive tract by gut microbes after eating red meat may help explain part of the higher risk of cardiovascular disease associated with red meat consumption, according to new research published today in the American Heart Association's peer-reviewed journal Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB).

In the United States and around the world, cardiovascular disease is the leading cause of death. While the risk of developing cardiovascular disease, including heart attack and stroke, increases with age, other risk factors are influenced by lifestyle. Lifestyle and behaviors that are known to Excellerate cardiovascular health include eating healthy foods, especially fruits and vegetables; regular physical activity; obtaining sufficient sleep; maintaining a healthy body weight; stopping smoking; and controlling high blood pressure, high cholesterol and high blood sugar.

Most of the focus on red meat intake and health has been around dietary saturated fat and blood cholesterol levels. Based on our findings, novel interventions may be helpful to target the interactions between red meat and the gut microbiome to help us find ways to reduce cardiovascular risk."

Meng Wang, Ph.D., co-lead author of the study, postdoctoral fellow at the Friedman School of Nutrition Science and Policy at Tufts University

Previous research has found that certain metabolites -; chemical byproducts of food digestion -; are associated with a greater risk of cardiovascular disease . One of these metabolites is TMAO, or trimethylamine N-oxide, which is produced by gut bacteria to digest red meat that contains high amounts of the chemical L-carnitine .

High blood levels of TMAO in humans may be associated with higher risks of CVD, chronic kidney disease and Type 2 diabetes. However, whether TMAO and related metabolites derived from L-carnitine may help explain the effects of red meat intake on cardiovascular risk, and to what extent they may contribute to cardiovascular risk associated with meat consumption, are still unknown.

To understand these questions, the researchers conducting this study measured levels of the metabolites in blood samples. They also examined whether blood sugar, inflammation, blood pressure and blood cholesterol may account for the elevated cardiovascular risk associated with red meat consumption.

Study participants included nearly 4,000 of the 5,888 adults initially recruited from 1989 to 1990 for the Cardiovascular Health Study (CHS). The participants selected for the current study were free of clinical cardiovascular disease at time of enrollment in the CHS, an observational study of risk factors for cardiovascular disease in adults aged 65 or older. The CHS follows 5,888 participants recruited from four communities: Sacramento, California; Hagerstown, Maryland; Winston-Salem, North Carolina; and Pittsburgh, Pennsylvania. The average age of participants at enrollment was 73, nearly two-thirds of participants were female and 88% of participants self-identified as white. The median follow-up time for participants was 12.5 years, and up to 26 years in some cases. At follow-up appointment, participants' medical history, lifestyle, health conditions and sociodemographic characteristics -; such as household income, education and age -; were assessed.

Several blood biomarkers were measured at the start of the study and again in 1996-1997. The fasting blood samples stored frozen at -80 ˚C were tested for levels of several gut-microbiome linked to red meat consumption including TMAO, gamma-butyrobetaine and crotonobetaine.

Additionally, all study participants answered two validated food-frequency questionnaires about their usual dietary habits, including intake of red meat, processed meat, fish, poultry and eggs, at the start of the study and again from 1995 to 1996. For the first questionnaire, participants indicated how often, on average in the previous 12 months, they had eaten given amounts of various foods, ranging from "never" to "almost every day or at least five times per week," based on medium portion sizes, which varied based on the food source. The second questionnaire used a ten-category frequency of average intake over the past 12 months, ranging from "never or less than once per month" to "six+ servings per day," with defined standard portion sizes.

For the current analyses, the researchers compared the risk of cardiovascular disease among participants who ate different amounts of animal source foods (i.e., red meat, processed meat, fish, chicken and eggs). They found that eating more meat, especially red meat and processed meat, was linked to a higher risk of atherosclerotic cardiovascular disease - a 22% higher risk for about every 1.1 serving per day .

According to the authors, the increase in TMAO and related metabolites found in the blood explained roughly one-tenth of this elevated risk. They also noted that blood sugar and general inflammation pathways may help explain the links between red meat intake and cardiovascular disease. Blood sugar and inflammation also appear to be more important in linking red meat intake and cardiovascular disease than pathways related to blood cholesterol or blood pressure. Intake of fish, poultry and eggs were not significantly linked to higher risk of cardiovascular disease.

"Research efforts are needed to better understand the potential health effects of L-carnitine and other substances in red meat such as heme iron, which has been associated with Type 2 diabetes, rather than just focusing on saturated fat," Wang said.

The study had several limitations that may have affected its results. The study was observational, meaning it could not control for all risk factors for cardiovascular disease, and may not prove cause and effect between meat consumption and cardiovascular disease or its mediation by gut microbe-generated chemicals. Additionally, food consumption was self-reported, so errors in reporting were possible. And, as most of the study participants were older, white men and women in the United States, the findings may not apply to populations that are younger or more racially diverse.


Journal reference:

Wang, M., et al. (2022) Dietary Meat, Trimethylamine N-Oxide-Related Metabolites, and Incident Cardiovascular Disease Among Older Adults: The Cardiovascular Health Study. Arteriosclerosis Thrombosis and Vascular Biology.

Mon, 01 Aug 2022 12:56:00 -0500 en text/html
Killexams : Cardiothoracic Surgeon John Craig, MD, FACS, Joins The Chattanooga Heart Institute

Cardiothoracic surgeon John Craig, MD, FACS, has joined The Chattanooga Heart Institute. 

Dr. Craig earned his medical degree from the University of Tennessee College of Medicine in Memphis, where he also completed a general surgery residency and a vascular surgery fellowship.  He completed a cardiothoracic surgery fellowship at Harvard Medical School’s Massachusetts General Hospital in Boston.  He specializes in all aspects of cardiac surgery.  Dr. Craig has more than a decade of experience as a cardiothoracic surgeon.

At The Chattanooga Heart Institute, Dr. Craig joins cardiothoracic surgeons Matthew Richey, MD, and James Zellner, MD, along with 27 cardiologists and three vascular surgeons.

"This team of experts is the region’s heart and vascular leader – providing compassionate care while effectively treating heart disease, no matter how complex," officials said. "The Chattanooga Heart Institute’s board-certified cardiologists—including specialists in interventional procedures, electrophysiology, imaging and vascular disease—exceed national standards for education, training and skill.  Their collaboration with cardiothoracic surgeons and vascular surgeons means they can offer the most comprehensive cardiac and vascular care in the area.

"In 2022, CHI Memorial was named best regional hospital by U. S. News and World Report. The healthcare system’s cardiac team was also recognized in 2022 as high performing in the treatment for heart attack and heart failure, heart bypass surgery and abdominal aortic aneurysm repair.  They are dedicated to providing patients with exceptional care using cutting-edge technology."

The Chattanooga Heart Institute offers seven locations in Tennessee and North Georgia.  Dr. Craig will practice at The Chattanooga Heart Institute office at 2501 Citico Ave. in Chattanooga. 

For more information or to schedule an appointment with one of The Chattanooga Heart Institute’s cardiothoracic surgeons, call 423-697-2000.

Thu, 28 Jul 2022 02:17:00 -0500 en text/html
ANCC-CVNC exam dump and training guide direct download
Training Exams List